Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Borrelia burgdorferi | 5 | 2024 | 184 | 1.930 |
Why?
|
Lyme Disease | 6 | 2024 | 631 | 1.670 |
Why?
|
Gonorrhea | 2 | 2024 | 354 | 1.330 |
Why?
|
Phylogeny | 5 | 2024 | 2832 | 1.150 |
Why?
|
Genome, Viral | 7 | 2024 | 670 | 1.120 |
Why?
|
Neisseria gonorrhoeae | 2 | 2024 | 248 | 0.950 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2024 | 335 | 0.820 |
Why?
|
Encephalitis Viruses, Tick-Borne | 4 | 2024 | 48 | 0.800 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 37 | 0.790 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.770 |
Why?
|
SAIDS Vaccines | 1 | 2022 | 144 | 0.740 |
Why?
|
Genetic Fitness | 1 | 2022 | 119 | 0.730 |
Why?
|
Babesia microti | 2 | 2019 | 31 | 0.670 |
Why?
|
Genome, Bacterial | 1 | 2024 | 797 | 0.640 |
Why?
|
Babesiosis | 2 | 2019 | 92 | 0.630 |
Why?
|
Genome, Protozoan | 3 | 2016 | 153 | 0.610 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 365 | 0.590 |
Why?
|
Plasmodium falciparum | 6 | 2013 | 1738 | 0.560 |
Why?
|
Disease Outbreaks | 3 | 2023 | 1759 | 0.540 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 496 | 0.520 |
Why?
|
AIDS Vaccines | 1 | 2022 | 898 | 0.520 |
Why?
|
Influenza Vaccines | 1 | 2022 | 778 | 0.480 |
Why?
|
Antigenic Variation | 1 | 2013 | 117 | 0.430 |
Why?
|
Encephalitis, Tick-Borne | 3 | 2024 | 45 | 0.420 |
Why?
|
Cell Nucleolus | 1 | 2013 | 155 | 0.420 |
Why?
|
Virus Shedding | 2 | 2022 | 111 | 0.370 |
Why?
|
Chromosomes | 1 | 2013 | 578 | 0.350 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7478 | 0.310 |
Why?
|
Metagenomics | 3 | 2024 | 473 | 0.300 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2024 | 618 | 0.290 |
Why?
|
Protozoan Proteins | 1 | 2013 | 843 | 0.280 |
Why?
|
Genetic Variation | 3 | 2024 | 6610 | 0.280 |
Why?
|
Antibodies, Neutralizing | 3 | 2024 | 2010 | 0.240 |
Why?
|
Ross River virus | 1 | 2024 | 6 | 0.240 |
Why?
|
Urethritis | 1 | 2024 | 30 | 0.240 |
Why?
|
Alphavirus Infections | 1 | 2024 | 20 | 0.240 |
Why?
|
Borrelia | 1 | 2024 | 66 | 0.230 |
Why?
|
Bayes Theorem | 2 | 2022 | 2354 | 0.230 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.210 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 231 | 0.210 |
Why?
|
Humans | 53 | 2024 | 765956 | 0.200 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.200 |
Why?
|
Virus Cultivation | 1 | 2022 | 88 | 0.200 |
Why?
|
DNA, Bacterial | 2 | 2024 | 1477 | 0.200 |
Why?
|
Convalescence | 1 | 2022 | 107 | 0.200 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 71 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3655 | 0.190 |
Why?
|
GATA2 Transcription Factor | 2 | 2013 | 158 | 0.190 |
Why?
|
Alanine | 1 | 2024 | 612 | 0.190 |
Why?
|
Ciprofloxacin | 1 | 2023 | 314 | 0.190 |
Why?
|
Erythema Chronicum Migrans | 1 | 2021 | 50 | 0.190 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.180 |
Why?
|
Anthozoa | 1 | 2021 | 65 | 0.180 |
Why?
|
Sequence Analysis | 1 | 2021 | 239 | 0.180 |
Why?
|
Cell Cycle | 1 | 2009 | 2920 | 0.180 |
Why?
|
Interferon Type I | 1 | 2024 | 567 | 0.180 |
Why?
|
Neutralization Tests | 1 | 2022 | 735 | 0.180 |
Why?
|
Meningitis | 1 | 2021 | 216 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 193 | 0.160 |
Why?
|
BCG Vaccine | 1 | 2022 | 380 | 0.160 |
Why?
|
Immunocompromised Host | 2 | 2024 | 866 | 0.160 |
Why?
|
Drug Resistance, Viral | 1 | 2024 | 866 | 0.160 |
Why?
|
Serologic Tests | 1 | 2021 | 382 | 0.160 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 975 | 0.160 |
Why?
|
Plasmids | 1 | 2023 | 2274 | 0.150 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2019 | 135 | 0.140 |
Why?
|
Viruses | 1 | 2021 | 371 | 0.140 |
Why?
|
Metagenome | 1 | 2021 | 464 | 0.140 |
Why?
|
Virus Replication | 2 | 2024 | 2447 | 0.140 |
Why?
|
Encephalitis | 1 | 2021 | 441 | 0.140 |
Why?
|
DNA Primers | 1 | 2021 | 2825 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9524 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 17533 | 0.140 |
Why?
|
Seasons | 1 | 2023 | 1524 | 0.140 |
Why?
|
Microbial Sensitivity Tests | 1 | 2023 | 1971 | 0.140 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3211 | 0.130 |
Why?
|
Atovaquone | 1 | 2016 | 56 | 0.130 |
Why?
|
Cytochromes b | 1 | 2016 | 35 | 0.130 |
Why?
|
Mutation | 7 | 2024 | 30196 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 591 | 0.130 |
Why?
|
RNA, Viral | 2 | 2021 | 2864 | 0.130 |
Why?
|
Drug Resistance, Bacterial | 1 | 2023 | 1069 | 0.130 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 1217 | 0.130 |
Why?
|
Autoantibodies | 1 | 2024 | 2113 | 0.130 |
Why?
|
Zoonoses | 1 | 2016 | 181 | 0.120 |
Why?
|
Polymerase Chain Reaction | 3 | 2021 | 6069 | 0.120 |
Why?
|
Azithromycin | 1 | 2016 | 201 | 0.120 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 366 | 0.110 |
Why?
|
Genotype | 3 | 2023 | 13024 | 0.110 |
Why?
|
DNA, Protozoan | 1 | 2013 | 226 | 0.100 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2013 | 82 | 0.100 |
Why?
|
Regression Analysis | 1 | 2022 | 6321 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14652 | 0.100 |
Why?
|
Leukopenia | 1 | 2013 | 213 | 0.100 |
Why?
|
DNA, Ribosomal | 1 | 2013 | 300 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2024 | 3050 | 0.100 |
Why?
|
Viral Load | 1 | 2021 | 3386 | 0.100 |
Why?
|
Amino Acid Substitution | 1 | 2016 | 1740 | 0.090 |
Why?
|
Ethanolamines | 1 | 2012 | 152 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6897 | 0.090 |
Why?
|
RNA, Antisense | 1 | 2011 | 135 | 0.090 |
Why?
|
Ritonavir | 2 | 2023 | 330 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2013 | 334 | 0.090 |
Why?
|
Fluorenes | 1 | 2012 | 160 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4772 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1539 | 0.090 |
Why?
|
Mycobacterium Infections | 1 | 2011 | 123 | 0.090 |
Why?
|
Nucleic Acid Conformation | 1 | 2013 | 901 | 0.080 |
Why?
|
New England | 2 | 2024 | 1059 | 0.080 |
Why?
|
Mycobacterium | 1 | 2011 | 253 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2022 | 3615 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2060 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2021 | 2412 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5929 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3776 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9338 | 0.070 |
Why?
|
Blood | 1 | 2010 | 597 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 1365 | 0.070 |
Why?
|
Whole-Body Irradiation | 1 | 2007 | 438 | 0.070 |
Why?
|
Microfluidics | 2 | 2022 | 651 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2023 | 26349 | 0.060 |
Why?
|
Animals | 12 | 2024 | 168759 | 0.060 |
Why?
|
United States | 4 | 2023 | 72898 | 0.060 |
Why?
|
Monocytes | 2 | 2013 | 2595 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4618 | 0.060 |
Why?
|
Infant | 3 | 2023 | 36385 | 0.060 |
Why?
|
Antimalarials | 1 | 2012 | 913 | 0.060 |
Why?
|
Flavivirus | 1 | 2024 | 23 | 0.060 |
Why?
|
Erythrocytes | 2 | 2012 | 2395 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2631 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9296 | 0.060 |
Why?
|
Temperature | 1 | 2010 | 2226 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8501 | 0.050 |
Why?
|
Models, Genetic | 1 | 2013 | 3448 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10850 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15880 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 651 | 0.050 |
Why?
|
Male | 12 | 2024 | 363691 | 0.050 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 62 | 0.050 |
Why?
|
Malaria | 1 | 2012 | 1246 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7875 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 481 | 0.050 |
Why?
|
Arthropod Vectors | 1 | 2020 | 6 | 0.050 |
Why?
|
Complement C5 | 1 | 2021 | 99 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9747 | 0.040 |
Why?
|
Ticks | 1 | 2020 | 72 | 0.040 |
Why?
|
Life Cycle Stages | 1 | 2020 | 161 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2012 | 12769 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2020 | 18973 | 0.040 |
Why?
|
Introns | 2 | 2013 | 966 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2021 | 471 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3426 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16047 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 791 | 0.040 |
Why?
|
Contact Tracing | 1 | 2021 | 274 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2729 | 0.040 |
Why?
|
Gene Expression | 1 | 2011 | 7584 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 346 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 837 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 323 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 223004 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1289 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 272 | 0.040 |
Why?
|
Fluorescence | 1 | 2020 | 753 | 0.040 |
Why?
|
Dietary Fats | 1 | 2005 | 2002 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 627 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 956 | 0.030 |
Why?
|
Tacrolimus | 1 | 2021 | 753 | 0.030 |
Why?
|
Adiposity | 1 | 2007 | 1890 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2020 | 651 | 0.030 |
Why?
|
Pandemics | 3 | 2022 | 8701 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 862 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6274 | 0.030 |
Why?
|
Biological Evolution | 1 | 2022 | 1072 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2406 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1965 | 0.030 |
Why?
|
Syndrome | 2 | 2013 | 3271 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11888 | 0.030 |
Why?
|
Adult | 7 | 2024 | 223038 | 0.030 |
Why?
|
Insulin Resistance | 2 | 2007 | 3985 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2417 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1037 | 0.030 |
Why?
|
Obesity | 2 | 2007 | 13075 | 0.030 |
Why?
|
Chemokine CCL2 | 2 | 2007 | 602 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1789 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54806 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 669 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36532 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20125 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2717 | 0.030 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.030 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2601 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3946 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1957 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3796 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1461 | 0.020 |
Why?
|
Aged | 5 | 2024 | 171114 | 0.020 |
Why?
|
Female | 9 | 2024 | 396101 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 649 | 0.020 |
Why?
|
AT Rich Sequence | 1 | 2010 | 10 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12807 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4258 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 461 | 0.020 |
Why?
|
Base Composition | 1 | 2010 | 291 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5379 | 0.020 |
Why?
|
Pseudogenes | 1 | 2010 | 104 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2535 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1160 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9649 | 0.020 |
Why?
|
Parasites | 1 | 2012 | 159 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81515 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18071 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8871 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 993 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2680 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1587 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2011 | 856 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1984 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3390 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4209 | 0.020 |
Why?
|
Hepatomegaly | 1 | 2007 | 83 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Drug Design | 1 | 2012 | 1042 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2011 | 1107 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7421 | 0.020 |
Why?
|
Mice, Obese | 1 | 2007 | 417 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2391 | 0.020 |
Why?
|
Time Factors | 2 | 2022 | 40065 | 0.020 |
Why?
|
RNA Splicing | 1 | 2010 | 903 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42500 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15398 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2005 | 752 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22222 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21480 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9249 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1823 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12403 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5876 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41647 | 0.010 |
Why?
|
Adiponectin | 1 | 2007 | 1119 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59886 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17594 | 0.010 |
Why?
|
Adipocytes | 1 | 2007 | 1194 | 0.010 |
Why?
|
Child | 2 | 2021 | 80563 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88832 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2007 | 22331 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59488 | 0.010 |
Why?
|
Brain | 1 | 2021 | 27178 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16721 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2005 | 3312 | 0.010 |
Why?
|
Blood Glucose | 1 | 2007 | 6425 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14447 | 0.010 |
Why?
|
Mice | 2 | 2007 | 81818 | 0.010 |
Why?
|
Concepts
(255)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(110)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_